Global Nuclear Medicine & Radiopharmaceuticals Market Insights, Forecast to 2025

Publisher Name :
Date: 25-Feb-2019
No. of pages: 121
Inquire Before Buying

The global Nuclear Medicine & Radiopharmaceuticals market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Nuclear Medicine & Radiopharmaceuticals market based on company, product type, end user and key regions.

This report studies the global market size of Nuclear Medicine & Radiopharmaceuticals in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Nuclear Medicine & Radiopharmaceuticals in these regions.

This research report categorizes the global Nuclear Medicine & Radiopharmaceuticals market by top players/brands, region, type and end user. This report also studies the global Nuclear Medicine & Radiopharmaceuticals market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Bracco Imaging

- Bayer

- Mallinckrodt

- Nordion

- Triad Isotopes

- Lantheus

- IBA Group

- GE Healthcare

- China Isotope & Radiation

- Jubilant Pharma

- Eli Lilly

- Advanced Accelerator Applications

- SIEMENS

- Dongcheng

- Navidea

Market size by Product

- Diagnostic Radioisotopes

- Therapeutic Radioisotopes

Market size by End User

- Oncology

- Cardiology

- Other

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Nuclear Medicine & Radiopharmaceuticals market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Nuclear Medicine & Radiopharmaceuticals market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Nuclear Medicine & Radiopharmaceuticals companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Nuclear Medicine & Radiopharmaceuticals submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Nuclear Medicine & Radiopharmaceuticals are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Nuclear Medicine & Radiopharmaceuticals market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Nuclear Medicine & Radiopharmaceuticals Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Nuclear Medicine & Radiopharmaceuticals Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate by Product
1.4.2 Diagnostic Radioisotopes
1.4.3 Therapeutic Radioisotopes
1.5 Market by End User
1.5.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate by End User
1.5.2 Oncology
1.5.3 Cardiology
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size
2.1.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue 2014-2025
2.1.2 Global Nuclear Medicine & Radiopharmaceuticals Sales 2014-2025
2.2 Nuclear Medicine & Radiopharmaceuticals Growth Rate by Regions
2.2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Regions
2.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Nuclear Medicine & Radiopharmaceuticals Sales by Manufacturers
3.1.1 Nuclear Medicine & Radiopharmaceuticals Sales by Manufacturers
3.1.2 Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Manufacturers
3.1.3 Global Nuclear Medicine & Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.2 Nuclear Medicine & Radiopharmaceuticals Revenue by Manufacturers
3.2.1 Nuclear Medicine & Radiopharmaceuticals Revenue by Manufacturers (2014-2019)
3.2.2 Nuclear Medicine & Radiopharmaceuticals Revenue Share by Manufacturers (2014-2019)
3.3 Nuclear Medicine & Radiopharmaceuticals Price by Manufacturers
3.4 Nuclear Medicine & Radiopharmaceuticals Manufacturing Base Distribution, Product Types
3.4.1 Nuclear Medicine & Radiopharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Nuclear Medicine & Radiopharmaceuticals Product Type
3.4.3 Date of International Manufacturers Enter into Nuclear Medicine & Radiopharmaceuticals Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Product
4.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Product
4.3 Nuclear Medicine & Radiopharmaceuticals Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Nuclear Medicine & Radiopharmaceuticals Breakdown Data by End User
6 North America
6.1 North America Nuclear Medicine & Radiopharmaceuticals by Countries
6.1.1 North America Nuclear Medicine & Radiopharmaceuticals Sales by Countries
6.1.2 North America Nuclear Medicine & Radiopharmaceuticals Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Nuclear Medicine & Radiopharmaceuticals by Product
6.3 North America Nuclear Medicine & Radiopharmaceuticals by End User
7 Europe
7.1 Europe Nuclear Medicine & Radiopharmaceuticals by Countries
7.1.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Countries
7.1.2 Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Nuclear Medicine & Radiopharmaceuticals by Product
7.3 Europe Nuclear Medicine & Radiopharmaceuticals by End User
8 Asia Pacific
8.1 Asia Pacific Nuclear Medicine & Radiopharmaceuticals by Countries
8.1.1 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Countries
8.1.2 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Nuclear Medicine & Radiopharmaceuticals by Product
8.3 Asia Pacific Nuclear Medicine & Radiopharmaceuticals by End User
9 Central & South America
9.1 Central & South America Nuclear Medicine & Radiopharmaceuticals by Countries
9.1.1 Central & South America Nuclear Medicine & Radiopharmaceuticals Sales by Countries
9.1.2 Central & South America Nuclear Medicine & Radiopharmaceuticals Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Nuclear Medicine & Radiopharmaceuticals by Product
9.3 Central & South America Nuclear Medicine & Radiopharmaceuticals by End User
10 Middle East and Africa
10.1 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals by Countries
10.1.1 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Countries
10.1.2 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals by Product
10.3 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals by End User
11 Company Profiles
11.1 Bracco Imaging
11.1.1 Bracco Imaging Company Details
11.1.2 Company Business Overview
11.1.3 Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Products Offered
11.1.5 Bracco Imaging Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Company Business Overview
11.2.3 Bayer Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Bayer Nuclear Medicine & Radiopharmaceuticals Products Offered
11.2.5 Bayer Recent Development
11.3 Mallinckrodt
11.3.1 Mallinckrodt Company Details
11.3.2 Company Business Overview
11.3.3 Mallinckrodt Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Mallinckrodt Nuclear Medicine & Radiopharmaceuticals Products Offered
11.3.5 Mallinckrodt Recent Development
11.4 Nordion
11.4.1 Nordion Company Details
11.4.2 Company Business Overview
11.4.3 Nordion Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Nordion Nuclear Medicine & Radiopharmaceuticals Products Offered
11.4.5 Nordion Recent Development
11.5 Triad Isotopes
11.5.1 Triad Isotopes Company Details
11.5.2 Company Business Overview
11.5.3 Triad Isotopes Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Triad Isotopes Nuclear Medicine & Radiopharmaceuticals Products Offered
11.5.5 Triad Isotopes Recent Development
11.6 Lantheus
11.6.1 Lantheus Company Details
11.6.2 Company Business Overview
11.6.3 Lantheus Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Lantheus Nuclear Medicine & Radiopharmaceuticals Products Offered
11.6.5 Lantheus Recent Development
11.7 IBA Group
11.7.1 IBA Group Company Details
11.7.2 Company Business Overview
11.7.3 IBA Group Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
11.7.4 IBA Group Nuclear Medicine & Radiopharmaceuticals Products Offered
11.7.5 IBA Group Recent Development
11.8 GE Healthcare
11.8.1 GE Healthcare Company Details
11.8.2 Company Business Overview
11.8.3 GE Healthcare Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
11.8.4 GE Healthcare Nuclear Medicine & Radiopharmaceuticals Products Offered
11.8.5 GE Healthcare Recent Development
11.9 China Isotope & Radiation
11.9.1 China Isotope & Radiation Company Details
11.9.2 Company Business Overview
11.9.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
11.9.4 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Products Offered
11.9.5 China Isotope & Radiation Recent Development
11.10 Jubilant Pharma
11.10.1 Jubilant Pharma Company Details
11.10.2 Company Business Overview
11.10.3 Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Products Offered
11.10.5 Jubilant Pharma Recent Development
11.11 Eli Lilly
11.12 Advanced Accelerator Applications
11.13 SIEMENS
11.14 Dongcheng
11.15 Navidea
12 Future Forecast
12.1 Nuclear Medicine & Radiopharmaceuticals Market Forecast by Regions
12.1.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Regions 2019-2025
12.1.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Regions 2019-2025
12.2 Nuclear Medicine & Radiopharmaceuticals Market Forecast by Product
12.2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Product 2019-2025
12.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Product 2019-2025
12.3 Nuclear Medicine & Radiopharmaceuticals Market Forecast by End User
12.4 North America Nuclear Medicine & Radiopharmaceuticals Forecast
12.5 Europe Nuclear Medicine & Radiopharmaceuticals Forecast
12.6 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Forecast
12.7 Central & South America Nuclear Medicine & Radiopharmaceuticals Forecast
12.8 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Nuclear Medicine & Radiopharmaceuticals Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Nuclear Medicine & Radiopharmaceuticals Product Picture
Table Nuclear Medicine & Radiopharmaceuticals Market Segments
Table Key Manufacturers Nuclear Medicine & Radiopharmaceuticals Covered
Table Global Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Product 2014-2025
Figure Diagnostic Radioisotopes Product Picture
Table Major Manufacturers of Diagnostic Radioisotopes
Figure Therapeutic Radioisotopes Product Picture
Table Major Manufacturers of Therapeutic Radioisotopes
Table Global Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Oncology
Figure Cardiology
Figure Other
Figure Nuclear Medicine & Radiopharmaceuticals Report Years Considered
Figure Global Nuclear Medicine & Radiopharmaceuticals Market Size 2014-2025 (Million US$)
Figure Global Nuclear Medicine & Radiopharmaceuticals Sales 2014-2025 (K Units)
Table Global Nuclear Medicine & Radiopharmaceuticals Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Nuclear Medicine & Radiopharmaceuticals Sales by Regions 2014-2019 (K Units)
Table Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Regions 2014-2019
Figure Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Regions 2014-2019
Figure 2018 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Regions
Table Global Nuclear Medicine & Radiopharmaceuticals Revenue by Regions 2014-2019 (Million US$)
Table Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Regions 2014-2019
Figure Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Regions 2014-2019
Figure 2018 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Regions
Table Global Nuclear Medicine & Radiopharmaceuticals Sales by Manufacturers (2014-2019) (K Units)
Table Global Nuclear Medicine & Radiopharmaceuticals Sales Share by Manufacturers (2014-2019)
Figure Global Nuclear Medicine & Radiopharmaceuticals Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Nuclear Medicine & Radiopharmaceuticals Revenue by Manufacturers (2014-2019) (Million USD)
Table Nuclear Medicine & Radiopharmaceuticals Revenue Share by Manufacturers (2014-2019)
Figure Nuclear Medicine & Radiopharmaceuticals Value Share by Manufacturers in 2018
Table Key Manufacturers Nuclear Medicine & Radiopharmaceuticals Price (2014-2019) (USD/Unit)
Table Nuclear Medicine & Radiopharmaceuticals Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Nuclear Medicine & Radiopharmaceuticals Product Type
Table Date of International Manufacturers Enter into Nuclear Medicine & Radiopharmaceuticals Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Nuclear Medicine & Radiopharmaceuticals Sales by Product (2014-2019) (K Units)
Table Global Nuclear Medicine & Radiopharmaceuticals Sales Share by Product (2014-2019)
Figure Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Product (2014-2019)
Figure Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Product in 2018
Table Global Nuclear Medicine & Radiopharmaceuticals Revenue by Product (2014-2019) (Million US$)
Table Global Nuclear Medicine & Radiopharmaceuticals Revenue Share by Product (2014-2019)
Figure Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Product (2014-2019)
Figure Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Product in 2018
Table Nuclear Medicine & Radiopharmaceuticals Price by Product 2014-2019 (USD/Unit)
Table Global Nuclear Medicine & Radiopharmaceuticals Sales by End User (2014-2019) (K Units)
Table Global Nuclear Medicine & Radiopharmaceuticals Sales Share by End User (2014-2019)
Figure Global Sales Nuclear Medicine & Radiopharmaceuticals Market Share by End User (2014-2019)
Figure Global Sales Nuclear Medicine & Radiopharmaceuticals Market Share by End User in 2018
Figure North America Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate 2014-2019 (K Units)
Figure North America Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2014-2019 (Million US$)
Table North America Nuclear Medicine & Radiopharmaceuticals Sales by Countries (2014-2019) (K Units)
Table North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Countries (2014-2019)
Figure 2018 North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Countries
Table North America Nuclear Medicine & Radiopharmaceuticals Revenue by Countries (2014-2019) (Million US$)
Table North America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Countries
Figure United States Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
Figure United States Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
Figure Canada Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
Table North America Nuclear Medicine & Radiopharmaceuticals Sales by Product (2014-2019) (K Units)
Table North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Product (2014-2019)
Figure 2018 North America Nuclear Medicine & Radiopharmaceuticals Market Share by Product
Table North America Nuclear Medicine & Radiopharmaceuticals Sales by End User (2014-2019) (K Units)
Table North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by End User (2014-2019)
Figure 2018 North America Nuclear Medicine & Radiopharmaceuticals Market Share by End User
Figure Europe Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate 2014-2019 (K Units)
Figure Europe Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Nuclear Medicine & Radiopharmaceuticals Sales by Countries (2014-2019) (K Units)
Table Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Countries
Table Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Countries (2014-2019) (Million US$)
Table Europe Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Countries
Figure Germany Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
Figure Germany Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
Figure France Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
Figure France Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
Figure UK Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
Figure Italy Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
Figure Russia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Nuclear Medicine & Radiopharmaceuticals Sales by Product (2014-2019) (K Units)
Table Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Product (2014-2019)
Figure 2018 Europe Nuclear Medicine & Radiopharmaceuticals Market Share by Product
Table Europe Nuclear Medicine & Radiopharmaceuticals Sales by End User (2014-2019) (K Units)
Table Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by End User (2014-2019)
Figure 2018 Europe Nuclear Medicine & Radiopharmaceuticals Market Share by End User
Figure Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Countries
Table Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Countries
Figure China Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
Figure China Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
Figure Japan Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
Figure Korea Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
Figure India Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
Figure India Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
Figure Australia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Product (2014-2019) (K Units)
Table Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Market Share by Product
Table Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales by End User (2014-2019) (K Units)
Table Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Market Share by End User
Figure Central & South America Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Nuclear Medicine & Radiopharmaceuticals Sales by Countries (2014-2019) (K Units)
Table Central & South America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Countries
Table Central & South America Nuclear Medicine & Radiopharmaceuticals Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Countries
Figure Brazil Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Nuclear Medicine & Radiopharmaceuticals Sales by Product (2014-2019) (K Units)
Table Central & South America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Nuclear Medicine & Radiopharmaceuticals Market Share by Product
Table Central & South America Nuclear Medicine & Radiopharmaceuticals Sales by End User (2014-2019) (K Units)
Table Central & South America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Nuclear Medicine & Radiopharmaceuticals Market Share by End User
Figure Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Countries
Table Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Countries
Figure GCC Countries Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Share by Product
Table Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Share by End User
Table Bracco Imaging Company Details
Table Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bracco Imaging Recent Development
Table Bayer Company Details
Table Bayer Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer Recent Development
Table Mallinckrodt Company Details
Table Mallinckrodt Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Mallinckrodt Recent Development
Table Nordion Company Details
Table Nordion Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Nordion Recent Development
Table Triad Isotopes Company Details
Table Triad Isotopes Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Triad Isotopes Recent Development
Table Lantheus Company Details
Table Lantheus Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Lantheus Recent Development
Table IBA Group Company Details
Table IBA Group Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table IBA Group Recent Development
Table GE Healthcare Company Details
Table GE Healthcare Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GE Healthcare Recent Development
Table China Isotope & Radiation Company Details
Table China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table China Isotope & Radiation Recent Development
Table Jubilant Pharma Company Details
Table Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Jubilant Pharma Recent Development
Table Eli Lilly Company Details
Table Advanced Accelerator Applications Company Details
Table SIEMENS Company Details
Table Dongcheng Company Details
Table Navidea Company Details
Table Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Regions 2019-2025 (K Units)
Table Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share Forecast by Regions 2019-2025
Table Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share Forecast by Regions 2019-2025
Table Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Product 2019-2025 (K Units)
Table Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share Forecast by Product 2019-2025
Table Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share Forecast by Product 2019-2025
Table Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by End User 2019-2025 (K Units)
Table Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share Forecast by End User 2019-2025
Figure North America Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Nuclear Medicine & Radiopharmaceuticals Value Chain
Table Nuclear Medicine & Radiopharmaceuticals Customers List
Table Nuclear Medicine & Radiopharmaceuticals Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • (Post-pandemic Era) - Global Human Fibrinogen Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026
    Published: 26-Oct-2020        Price: US 3650 Onwards        Pages: 130
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • (Post-pandemic Era) - Global Human Fibrinogen Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 26-Oct-2020        Price: US 3620 Onwards        Pages: 136
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Human Fibrinogen Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
    Published: 26-Oct-2020        Price: US 3160 Onwards        Pages: 105
    Summary At the time of this report, the official counts of cases and deaths from COVID-19 have passed 4,000,000 and 280,000. Many government announced a plan on reopening the national economy, but many countries are still at the stage of rising. It should be noted that the impact of the epidemic has accelerated the trend of localization, regionalization and decentralization of the global industrial chain and supply chain, so it is inevitable to reconstruct the global industrial ch......
  • (Post-pandemic Era) - Global Ginkgo Biloba Extract Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026
    Published: 26-Oct-2020        Price: US 3650 Onwards        Pages: 134
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • (Post-pandemic Era) - Global Ginkgo Biloba Extract Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 26-Oct-2020        Price: US 3620 Onwards        Pages: 132
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Ginkgo Biloba Extract Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
    Published: 26-Oct-2020        Price: US 3160 Onwards        Pages: 108
    Summary At the time of this report, the official counts of cases and deaths from COVID-19 have passed 4,000,000 and 280,000. Many government announced a plan on reopening the national economy, but many countries are still at the stage of rising. It should be noted that the impact of the epidemic has accelerated the trend of localization, regionalization and decentralization of the global industrial chain and supply chain, so it is inevitable to reconstruct the global industrial ch......
  • (Post-pandemic Era) - Global Dental Silica Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026
    Published: 26-Oct-2020        Price: US 3650 Onwards        Pages: 133
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • (Post-pandemic Era) - Global Dental Silica Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 26-Oct-2020        Price: US 3620 Onwards        Pages: 135
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Dental Silica Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
    Published: 26-Oct-2020        Price: US 3160 Onwards        Pages: 106
    Summary At the time of this report, the official counts of cases and deaths from COVID-19 have passed 4,000,000 and 280,000. Many government announced a plan on reopening the national economy, but many countries are still at the stage of rising. It should be noted that the impact of the epidemic has accelerated the trend of localization, regionalization and decentralization of the global industrial chain and supply chain, so it is inevitable to reconstruct the global industrial ch......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs